Pear Therapeutics, Inc.

200 State Street, 13th Floor

Boston, Massachusetts 02109

December 29, 2021

VIA EDGAR

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Re: Pear Therapeutics, Inc. Registration Statement on Form S-1 File No. 333-261876 Request for Acceleration

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, Pear Therapeutics, Inc. (the “Company”) hereby requests acceleration of the effective date of its Registration Statement on Form S-1 (File No. 333-261876) (the “Registration Statement”), so that it may become effective at 4:00 pm Eastern time on December 30, 2021, or as soon thereafter as practicable.

[Remainder of this page intentionally left blank]

Very truly yours, PEAR THERAPEUTICS, INC.
By:	/s/ Ronan O’Brien
	Name: Ronan O’Brien Title: General Counsel

[Signature Page to Pear Therapeutics, Inc. Acceleration Request]